There are two listings on this page:
| Generic name | Azacitidine |
| Pronunciation | ay-za-SITE-i-deen |
| Brand name(s), other common name(s) | Onureg® |
| Drug type | Nucleoside metabolic inhibitor |
| How the drug is given | Tablets, for oral use |
Indications and Usage
Onureg® is a indicated for continued treatment of adult patients with acute myeloid leukemia who achieved first complete remission (CR) or complete remission with incomplete blood count recovery (CRi) following intensive induction chemotherapy and are not able to complete intensive curative therapy.
Side effects needing medical attention
The most common adverse reactions are nausea, vomiting, diarrhea, fatigue, constipation, pneumonia, abdominal pain, joint pain/stiffness (arthralgia), decreased appetite, febrile neutropenia, dizziness, and pain in extremity.
Indications and Usage
Vidaza® is FDA approved to treat people who have certain myelodysplastic syndrome subtypes and chronic myelomonocytic leukemia.
Side effects needing medical attention
Black, tarry stools; bladder pain; bleeding gums; blood in urine or stool; cloudy urine; body aches or pain; burning or stinging of skin; chest pain or tightness in the chest; chills; ear, nose or chest congestion; cough; diarrhea; difficulty breathing, shortness of breath or wheezing; difficulty swallowing; dizziness; fast heartbeat; fever; frequent urge to urinate; headache; hives; hoarseness; itching; loss of voice or voice changes; lower back or side pain; muscle aches; nausea or vomiting; pain or tenderness around eyes and cheekbones; painful cold sores or blisters on lips, nose, eyes or genitals; painful or difficult urination; pain, redness, swelling, tenderness or warmth on skin; pale skin; pinhead-sized red spots on skin; puffiness or swelling of the eyelids or around the eyes, face, lips or tongue; rapid heartbeat; sore throat; sores, ulcers, or white spots on lips or in mouth; swollen glands; tender, swollen glands in neck; troubled breathing with exertion; unusual bleeding or bruising; unusual tiredness or weakness.
For information on how to manage the costs of drug therapy, please see Financial Support, or to speak with an Information Specialist, call (800) 955-4572.